Plasma Derived Therapy Market Trends

Growth Drivers

• Increasing centers for plasma collection units - The number of plasma collection units is growing globally in addition to the rise in therapeutic treatments involving blood components. One of the major drivers of the plasma derived treatment market's expansion is the swiftly increasing need for plasma therapeutic procedures.
  
  Greater acceptability of these treatments has also resulted from individuals becoming more aware of the therapeutic choices that are accessible to them. According to WHO, around 118.5 million blood donations are collected across the world, 40% of these are composed of high-income countries, which are home to 16% of the world’s population.
   
• Growing awareness and adoption of immunoglobulin - An increasing number of people in the healthcare industry are becoming aware of the sophisticated methods that use immunoglobulin to cure illnesses. As a result, immunoglobulin is now widely used to treat a variety of illnesses that are becoming more common in society.
  
  According to the latest report, the highest usage of immunoglobulin was found in adult patients having neurological, immunological, and hematological disorders. Moreover, in 2020, 91% (interquartile range 77%–99%) of immunoglobulin (IG) was prescribed as intravenous IG (IVIG) and 9% as subcutaneous Ig (SCIg) (IQR 4%–28%).
• Increasing rate of genetic disorders - Genetic disorders occur due to mutation in genes and congenital abnormalities and are mainly observed in live births, and pediatric hospital admissions and cause the majority of childhood deaths in developed countries.
  
  Moreover, Thalassaemia and sickle-cell anemia deficiency are the most common single-gene disorders recorded worldwide. According to WHO, around 240,000 newborns die every year around the world within 28 days by cause of congenital disorders. In addition, congenital disorders caused a further 170,000 deaths of children among the ages of 1 month and 5 years in 2023.

Challenges

• High cost of treatment procedures - The usage of modern treatment options surges the cost of treatment and further lands common people with additional pressure. Additionally, rapid changes in the facilities and schemes launched by the government to support the people economically have restricted the market’s growth.
   
• Strict regulations set by the government - The government has imposed strict rules and regulations regarding the manufacturing and production of drugs and medicines that have challenged the growth of the plasma derived therapy market to a great extent. With the growing awareness among people regarding the side effects of various drugs and medicines, plasma-derived therapy needs to prove its efficacy by keeping the number of side effects to a minimum number.